Photo of Megan Murray

Megan Murray, M.D., Sc.D.

Ronda Stryker and William Johnston Professor of Global Health, Harvard Medical School
Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health
Associate Professor of Medicine, Brigham and Women's Hospital
Director of Research, Global Health & Social Medicine, Harvard Medical School

Megan Murray, MD, MPH, ScD is an epidemiologist and an infectious disease physician with over 25 years of experience in the management of TB programs and TB epidemiology, as well as the transmission dynamics of emerging infectious diseases. She is a Professor of Global Health and Social Medicine and an Associate Professor of Medicine at Harvard Medical School, where she leads the Global Health Research Core, a multidisciplinary group of researchers who work with the Global Health Delivery Partnership faculty and staff to develop its mission to link research to the teaching and service activities of the Partnership. She is also a Professor of Epidemiology at Harvard School of Public Health and the Director of Research at the Brigham and Women’s Hospital Division of Global Health Equity and its sister organization, Partners In Health.  Dr. Murray has conducted field studies in Peru, Rwanda, South Africa, Ukraine, Russia and the US, and has previously worked in Kenya, Niger and Pakistan. Her current interests include identifying ways to reduce the suffering caused by the health impacts of climate change, especially in low and middle income countries.

Address: 
Department of Global Health and Social Medicine
641 Huntington Avenue
Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Dr. Murray’s research focuses on host and pathogen specific determinants of TB infection, disease and treatment outcomes. Much of her research is done in collaboration with the non-governmental organization Partners in Health and its Peru-based sister organization Socios en Salud. The joint team uses bacterial and human genetic and genomic tools to identify variants of interest and to understand the mechanisms of their interactions.

In addition to her work in Peru, Dr. Murray has conducted field studies in South Africa, Russia, the US, India, Indonesia, Sierra Leone, Pakistan, Niger and Rwanda. She serves as an editor for PLoS Medicine and for the European Journal of Epidemiology. She is currently a member of the Mass Consortium for Pathogen Readiness leadership team as well as Harvard University’s Covid Monitoring Committee. She has also served on numerous other committees, including the WHO’s TB-STAG, the Stop TB MDR Working Group, Harvard University Human Subjects Committee, the University’s Pandemic Flu Advisory Committee, the Institute of Medicine committee on Gulf War and Infectious Diseases, and multiple NIH study sections.

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.
Authors: Authors: Cohen T, Lipsitch M, Walensky RP, Murray M.
Proc Natl Acad Sci U S A
View full abstract on Pubmed
Public health. A National Tuberculosis Archive.
Authors: Authors: Gessler D, Dye C, Farmer P, Murray M, Navin T, Reves R, Shinnick T, Small PM, Yates T, Simpson G.
Science
View full abstract on Pubmed
Cost-effectiveness of alternative blood-screening strategies for West Nile Virus in the United States.
Authors: Authors: Korves CT, Goldie SJ, Murray MB.
PLoS Med
View full abstract on Pubmed
Incident tuberculosis among recent US immigrants and exogenous reinfection.
Authors: Authors: Cohen T, Murray M.
Emerg Infect Dis
View full abstract on Pubmed
Expanding tuberculosis case detection by screening household contacts.
Authors: Authors: Becerra MC, Pachao-Torreblanca IF, Bayona J, Celi R, Shin SS, Kim JY, Farmer PE, Murray M.
Public Health Rep
View full abstract on Pubmed
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.
Authors: Authors: Cohen T, Murray M.
Nat Med
View full abstract on Pubmed
Insertions, deletions, and single-nucleotide polymorphisms at rare restriction enzyme sites enhance discriminatory power of polymorphic amplified typing sequences, a novel strain typing system for Escherichia coli O157:H7.
Authors: Authors: Kudva IT, Griffin RW, Murray M, John M, Perna NT, Barrett TJ, Calderwood SB.
J Clin Microbiol
View full abstract on Pubmed
Isoniazid resistance and the future of drug-resistant tuberculosis.
Authors: Authors: Cohen T, Becerra MC, Murray MB.
Microb Drug Resist
View full abstract on Pubmed
Transmission dynamics and control of severe acute respiratory syndrome.
Authors: Authors: Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M.
Science
View full abstract on Pubmed
Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis.
Authors: Authors: Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K, Kokoris M, Duesterhoeft A, Eisen JA, Fraser CM, Fleischmann RD.
J Bacteriol
View full abstract on Pubmed